Compugen Ltd. Stock News

Does Compugen (CGEN) have what it takes to be a top stock pick for momentum investors? Let's find out.

Compugen Ltd. (NASDAQ:CGEN ) Q4 2023 Earnings Conference Call March 5, 2024 8:30 AM ET Company Participants Yvonne Naughton - Head of Investor Relations and Corporate Communications Anat Cohen-Dayag -

Compugen (CGEN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Does Compugen (CGEN) have what it takes to be a top stock pick for momentum investors? Let's find out.

While investors should probably direct the majority of their market-earmarked funds toward slow-and-steady ideas – à la Warren Buffett – sometimes, we end up with gambling money. And in that case

iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must Watch

Gilead Sciences, Inc. (NASDAQ:GILD) announced that it has entered into an agreement with Compugen Ltd (NASDAQ:CGEN) to exclusively license Compugen's pre-clinical antibody program against IL-18 bindi

Stocks are up today and investors wondering why will want to keep reading as we have a breakdown of the market's rally on Tuesday! The big catalyst keeping stocks up today comes from high investor hop

Compugen (NASDAQ: CGEN ) stock is rocketing higher on Tuesday after announcing an exclusive licensing agreement with Gilead Sciences (NASDAQ: GILD ). According to a press release from Compugen, this a

Compugen Ltd.'s stock CGEN, -3.36% was up by 113% in premarket trading on Tuesday after the company said it agreed to sell exclusive rights to Gilead Sciences Inc. GILD, -1.03% for later stage develop

Conference call today, December 19, 2023, 8:30 AM ET to discuss the license agreement HOLON, Israel , Dec. 19, 2023 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer im

You know you want it. High-potential penny stocks that is.

Here is how Compugen (CGEN) and Evogene (EVGN) have performed compared to their sector so far this year.

Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas' attack on Israel.

Here is how Compugen (CGEN) and Corcept Therapeutics (CORT) have performed compared to their sector so far this year.